Related Experiment Video
Updated: Jun 24, 2025

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
PPARα phosphorylation regulates colorectal tumor immune escape
Qian Gou1, Xiaoqing Tian1, Chen Dong1
1School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu Province, The People's Republic of China.
Loss of PPARα promotes colorectal cancer immune escape by increasing PD-L1 expression. Targeting the ERK-PPARα pathway with inhibitors and agonists may enhance anti-tumor immunity.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- High PD-L1 levels in cancer cells drive immune escape and hinder immunotherapy.
- Mechanisms of PD-L1 gene transcriptional repression remain largely unknown.
Purpose of the Study:
- To investigate the role of Peroxisome-Proliferator-Activated Receptor alpha (PPARα) in colorectal tumor immune escape.
- To elucidate the molecular mechanisms by which PPARα regulates PD-L1 expression.
Main Methods:
- Analysis of PPARα's role in colorectal tumor immune escape.
- Investigation of PPARα binding to the PD-L1 promoter.
- Assessment of PPARα agonist and ERK inhibitor effects on PD-L1 expression and T cell activity.
Main Results:
- Loss of PPARα was found to promote colorectal tumor immune escape.
- PPARα directly binds to the PD-L1 promoter, repressing its transcription.
- ERK-induced phosphorylation of PPARα blocks its repressive function, increasing PD-L1 levels.
- Combined treatment with an ERK inhibitor and PPARα agonist significantly reduced tumor immune escape.
Conclusions:
- The ERK-PPARα pathway plays a critical role in regulating PD-L1 gene transcription.
- Inhibition of this pathway represents a potential therapeutic strategy to overcome tumor immune escape in colorectal cancer.
More Related Videos
06:19Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
Published on: July 18, 2017
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...